Revenue Summary of IntelGenx Technologies Corp.

IntelGenx Technologies Corp.'s latest annual revenue in 2023 was 1.03 Million USD , up 9.37% from previous year.
IntelGenx Technologies Corp.'s latest quarterly revenue in 2024 Q1 was 174 Thousand USD , down -59.15% from previous quarter.
IntelGenx Technologies Corp. reported a annual revenue of 950 Thousand USD in annual revenue 2022, down -38.11% from previous year.
IntelGenx Technologies Corp. reported a annual revenue of 1.53 Million USD in annual revenue 2021, down -0.58% from previous year.
IntelGenx Technologies Corp. reported a quarterly revenue of 133 Thousand USD for 2023 Q2, down -17.9% from previous quarter.
IntelGenx Technologies Corp. reported a quarterly revenue of 318 Thousand USD for 2023 Q3, up 139.1% from previous quarter.

Annual Revenue Chart of IntelGenx Technologies Corp. (2023 - 2003)

Historical Annual Revenue of IntelGenx Technologies Corp. (2023 - 2003)

Year	Revenue	Revenue Growth
2023	1.03 Million USD	9.37%
2022	950 Thousand USD	-38.11%
2021	1.53 Million USD	-0.58%
2020	1.54 Million USD	108.09%
2019	742 Thousand USD	-59.32%
2018	1.82 Million USD	-64.89%
2017	5.19 Million USD	-0.48%
2016	5.22 Million USD	2.45%
2015	5.09 Million USD	207.11%
2014	1.65 Million USD	75.0%
2013	948 Thousand USD	-21.52%
2012	1.2 Million USD	174.55%
2011	440 Thousand USD	-67.09%
2010	1.33 Million USD	4.56%
2009	1.27 Million USD	30.93%
2008	976.61 Thousand USD	16.9%
2007	835.41 Thousand USD	214.18%
2006	265.9 Thousand USD	0.0%
2005	- USD	0.0%
2004	- USD	0.0%
2003	- USD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	174 Thousand USD	-59.15%
2023 Q2	133 Thousand USD	-17.9%
2023 Q3	318 Thousand USD	139.1%
2023 FY	1.03 Million USD	9.37%
2023 Q4	426 Thousand USD	33.96%
2023 Q1	162 Thousand USD	-6.36%
2022 Q1	237 Thousand USD	-52.02%
2022 FY	950 Thousand USD	-38.11%
2022 Q2	398 Thousand USD	67.93%
2022 Q3	142 Thousand USD	-64.32%
2022 Q4	173 Thousand USD	21.83%
2021 Q1	286 Thousand USD	-63.8%
2021 FY	1.53 Million USD	-0.58%
2021 Q2	162 Thousand USD	-43.36%
2021 Q4	494 Thousand USD	-16.69%
2021 Q3	593 Thousand USD	266.05%
2020 Q4	790 Thousand USD	54.9%
2020 Q3	510 Thousand USD	1114.29%
2020 Q1	202 Thousand USD	197.06%
2020 FY	1.54 Million USD	108.09%
2020 Q2	42 Thousand USD	-79.21%
2019 Q1	416 Thousand USD	-36.1%
2019 Q4	68 Thousand USD	11.48%
2019 Q3	61 Thousand USD	-69.04%
2019 Q2	197 Thousand USD	-52.64%
2019 FY	742 Thousand USD	-59.32%
2018 Q3	700 Thousand USD	199.15%
2018 Q2	234 Thousand USD	-2.09%
2018 Q1	239 Thousand USD	-83.65%
2018 FY	1.82 Million USD	-64.89%
2018 Q4	651 Thousand USD	-7.0%
2017 Q4	1.46 Million USD	16.59%
2017 FY	5.19 Million USD	-0.48%
2017 Q3	1.25 Million USD	11.37%
2017 Q2	1.12 Million USD	-16.78%
2017 Q1	1.35 Million USD	-29.2%
2016 Q2	672 Thousand USD	-17.85%
2016 Q4	1.91 Million USD	5.06%
2016 FY	5.22 Million USD	2.45%
2016 Q3	1.81 Million USD	170.68%
2016 Q1	818 Thousand USD	-45.54%
2015 FY	5.09 Million USD	207.11%
2015 Q4	1.5 Million USD	-36.97%
2015 Q2	585 Thousand USD	-6.4%
2015 Q1	625 Thousand USD	-24.24%
2015 Q3	2.38 Million USD	307.35%
2014 Q2	160 Thousand USD	-27.93%
2014 FY	1.65 Million USD	75.0%
2014 Q4	825 Thousand USD	82.52%
2014 Q3	452 Thousand USD	182.5%
2014 Q1	222 Thousand USD	54.17%
2013 Q4	144 Thousand USD	44.0%
2013 FY	948 Thousand USD	-21.52%
2013 Q3	100 Thousand USD	-81.72%
2013 Q2	547 Thousand USD	248.41%
2013 Q1	157 Thousand USD	-85.46%
2012 Q3	3000.00 USD	-85.71%
2012 Q4	1.08 Million USD	35900.0%
2012 FY	1.2 Million USD	174.55%
2012 Q1	285 Thousand USD	4.78%
2012 Q2	21 Thousand USD	-92.63%
2011 Q1	98 Thousand USD	-20.33%
2011 Q2	46 Thousand USD	-53.06%
2011 Q4	272 Thousand USD	1033.33%
2011 Q3	24 Thousand USD	-47.83%
2011 FY	440 Thousand USD	-67.09%
2010 Q2	126 Thousand USD	-30.77%
2010 Q1	182 Thousand USD	-6.14%
2010 FY	1.33 Million USD	4.56%
2010 Q3	906 Thousand USD	619.05%
2010 Q4	123 Thousand USD	-86.42%
2009 Q2	500.4 Thousand USD	148.96%
2009 Q3	383.4 Thousand USD	-23.38%
2009 Q1	201 Thousand USD	-15.66%
2009 FY	1.27 Million USD	30.93%
2009 Q4	193.9 Thousand USD	-49.43%
2008 Q4	238.33 Thousand USD	-15.54%
2008 Q1	144.99 Thousand USD	-37.85%
2008 Q2	298 Thousand USD	105.52%
2008 Q3	282.17 Thousand USD	-5.31%
2008 FY	976.61 Thousand USD	16.9%
2007 Q2	335.92 Thousand USD	284.11%
2007 Q3	178.73 Thousand USD	-46.79%
2007 Q4	233.3 Thousand USD	30.53%
2007 FY	835.41 Thousand USD	214.18%
2007 Q1	87.45 Thousand USD	45.96%
2006 Q3	17.29 Thousand USD	-81.43%
2006 Q4	59.91 Thousand USD	246.38%
2006 FY	265.9 Thousand USD	0.0%
2006 Q1	- USD	0.0%
2006 Q2	93.16 Thousand USD	0.0%
2005 Q1	- USD	0.0%
2005 Q3	- USD	0.0%
2005 FY	- USD	0.0%
2005 Q4	- USD	0.0%
2005 Q2	- USD	0.0%
2004 Q3	- USD	0.0%
2004 Q4	- USD	0.0%
2004 FY	- USD	0.0%
2004 Q2	- USD	0.0%
2004 Q1	- USD	0.0%
2003 FY	- USD	0.0%

Peer Revenue Comparison of IntelGenx Technologies Corp.

Name	Revenue	Revenue Difference
HST Global, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	-339.212%
WPD Pharmaceuticals Inc.	- USD	-Infinity%
CytoDyn Inc.	- USD	-Infinity%
RVL Pharmaceuticals plc	49.72 Million USD	97.91%
Advanced Proteome Therapeutics Corporation	- USD	-Infinity%
MultiCell Technologies, Inc.	49.32 USD	-2106550.446%
ImmunoCellular Therapeutics, Ltd.	- USD	-Infinity%
Arch Therapeutics, Inc.	75.72 Thousand USD	-1272.088%
THC Farmaceuticals, Inc.	- USD	-Infinity%
Reve Technologies, Inc.	- USD	-Infinity%
Sienna Biopharmaceuticals, Inc.	- USD	-Infinity%
Alpha Cognition Inc.	- USD	-Infinity%
Northwest Biotherapeutics, Inc.	1.93 Million USD	46.222%
SQZ Biotechnologies Company	21.47 Million USD	95.162%
Resverlogix Corp.	- USD	-Infinity%
Neon Bloom, Inc.	- USD	-Infinity%
VioQuest Pharmaceuticals, Inc.	- USD	-Infinity%
Sigyn Therapeutics, Inc.	- USD	-Infinity%
Mesoblast Limited	5.9 Million USD	82.396%
GB Sciences, Inc.	- USD	-Infinity%
Regen BioPharma, Inc.	236.56 Thousand USD	-339.212%
Evofem Biosciences, Inc.	18.21 Million USD	94.297%
Inhibitor Therapeutics, Inc.	- USD	-Infinity%
TetraLogic Pharmaceuticals Corporation	- USD	-Infinity%
Oncotelic Therapeutics, Inc.	70 Thousand USD	-1384.286%
VitaSpring Biomedical Co. Ltd.	- USD	-Infinity%
Nuo Therapeutics, Inc.	608.52 Thousand USD	-70.741%
ContraFect Corporation	- USD	-Infinity%
AXIM Biotechnologies, Inc.	39.51 Thousand USD	-2529.182%
BioStem Technologies, Inc.	16.68 Million USD	93.773%
LadRx Corporation	- USD	-Infinity%
Acro Biomedical Co., Ltd.	658.5 Thousand USD	-57.783%
Pathfinder Cell Therapy, Inc.	- USD	-Infinity%
CSL Limited	14.69 Billion USD	99.993%
Biomind Labs Inc.	- USD	-Infinity%
CNBX Pharmaceuticals Inc.	410.16 Thousand USD	-153.313%
Santhera Pharmaceuticals Holding AG	122.95 Million USD	99.155%
Nascent Biotech, Inc.	- USD	-Infinity%
Eiger BioPharmaceuticals, Inc.	15.77 Million USD	93.413%
Nanobac Pharmaceuticals, Incorporated	17.62 Thousand USD	-5796.374%
GeneThera, Inc.	- USD	-Infinity%
Emmaus Life Sciences, Inc.	29.59 Million USD	96.49%
Adynxx, Inc.	- USD	-Infinity%
Propanc Biopharma, Inc.	- USD	-Infinity%
Marizyme, Inc.	645.81 Thousand USD	-60.883%
Nymox Pharmaceutical Corporation	- USD	-Infinity%
Alseres Pharmaceuticals, Inc.	473.73 Thousand USD	-119.323%
Zenith Capital Corp.	- USD	-Infinity%
Intellipharmaceutics International Inc.	65.72 Thousand USD	-1480.757%
Halberd Corporation	999.00 USD	-103904.004%
Genus plc	668.8 Million USD	99.845%
Pharming Group N.V.	245.31 Million USD	99.576%
MetaStat, Inc.	- USD	-Infinity%
Therapeutic Solutions International, Inc.	98.99 Thousand USD	-949.559%
IMV Inc.	- USD	-Infinity%
Affymax, Inc.	1.36 Million USD	24.105%
SYBLEU INC	11.69 Thousand USD	-8783.379%
Enzon Pharmaceuticals, Inc.	- USD	-Infinity%
Enzolytics Inc.	52.79 Thousand USD	-1867.952%
argenx SE	1.22 Billion USD	99.915%
AVAX Technologies, Inc.	617.38 Thousand USD	-68.291%
RegeneRx Biopharmaceuticals, Inc.	76.76 Thousand USD	-1253.552%
Burzynski Research Institute, Inc.	- USD	-Infinity%
Anthera Pharmaceuticals, Inc.	- USD	-Infinity%
Accustem Sciences Inc.	- USD	-Infinity%
NDT Pharmaceuticals Inc.	- USD	-Infinity%
Cell Source, Inc.	- USD	-Infinity%
Arno Therapeutics, Inc.	- USD	-Infinity%
EV Biologics, Inc.	48.9 Thousand USD	-2024.744%
Q BioMed Inc.	284.35 Thousand USD	-265.392%
Rasna Therapeutics, Inc.	- USD	-Infinity%
Capstone Therapeutics Corp.	48.35 Million USD	97.851%
Mosaic ImmunoEngineering Inc.	- USD	-Infinity%
PsyBio Therapeutics Corp.	- USD	-Infinity%
American Oriental Bioengineering, Inc.	145.09 Million USD	99.284%
Provectus Biopharmaceuticals, Inc.	557.71 Thousand USD	-86.298%
Rebus Holdings, Inc.	- USD	-Infinity%
Helix BioMedix, Inc.	997.72 Thousand USD	-4.137%
Skye Bioscience, Inc.	- USD	-Infinity%
GlobeStar Therapeutics Corporation	- USD	-Infinity%
Cotinga Pharmaceuticals Inc.	- USD	-Infinity%
ONE Bio Corp.	52.29 Million USD	98.013%
Curative Biotechnology, Inc.	- USD	-Infinity%
Wesana Health Holdings Inc.	- USD	-Infinity%
Agentix Corp.	- USD	-Infinity%
Endonovo Therapeutics, Inc.	140.24 Thousand USD	-640.862%
RespireRx Pharmaceuticals Inc.	- USD	-Infinity%
Ember Therapeutics, Inc.	- USD	-Infinity%
Kadimastem Ltd	- USD	-Infinity%
Oncology Pharma Inc.	- USD	-Infinity%
Institute of Biomedical Research Corp.	- USD	-Infinity%
ProtoKinetix, Incorporated	- USD	-Infinity%
NovAccess Global Inc.	- USD	-Infinity%
Itoco Inc.	- USD	-Infinity%
Claritas Pharmaceuticals, Inc.	- USD	-Infinity%
NanoSphere Health Sciences Inc.	- USD	-Infinity%
Qrons Inc.	- USD	-Infinity%
Mobile Lads Corp.	- USD	-Infinity%
Genscript Biotech Corporation	839.52 Million USD	99.876%
International Stem Cell Corporation	7.78 Million USD	86.661%
Bioxytran, Inc.	- USD	-Infinity%
GlobeImmune, Inc.	- USD	-Infinity%
Predictive Technology Group, Inc.	- USD	-Infinity%
ProText Mobility, Inc.	- USD	-Infinity%
Cardax, Inc.	- USD	-Infinity%
VG Life Sciences Inc.	- USD	-Infinity%
Kaleido Biosciences, Inc.	- USD	-Infinity%
Advaxis, Inc.	13 Thousand USD	-7892.308%
Adhera Therapeutics, Inc.	- USD	-Infinity%
RenovaCare, Inc.	- USD	-Infinity%
Regnum Corp.	- USD	-Infinity%
Innovation Pharmaceuticals Inc.	- USD	-Infinity%
Neutra Corp.	39.53 Thousand USD	-2528.118%
Windtree Therapeutics, Inc.	- USD	-Infinity%
PureTech Health plc	3.33 Million USD	68.799%
Coeptis Therapeutics, Inc.	- USD	-Infinity%
IXICO plc	6.66 Million USD	84.411%
Gelesis Holdings, Inc.	25.76 Million USD	95.968%
CSL Limited	14.8 Billion USD	99.993%
Cellectis S.A.	755 Thousand USD	-37.616%

Global Stocks Search

IntelGenx Technologies Corp. (IGXT)

Revenue Summary of IntelGenx Technologies Corp.

Annual Revenue Chart of IntelGenx Technologies Corp. (2023 - 2003)

Historical Annual Revenue of IntelGenx Technologies Corp. (2023 - 2003)

Peer Revenue Comparison of IntelGenx Technologies Corp.